In a recent lung cancer study by Liu et al., [71] RNA interference and overexpression of ALDH isozymes suggested that ALDH1A1, which plays a key role in ALDH1-positive NSCLC stem cells, may be a target for the Disulfiram/CuCl2 complex, where DSF was shown to target ALDH1A1 and inhibit NSCLC recurrence driven by ALDH1-positive CSCs. Here, ALDH1A1 is linked to non-small cell lung carcinoma.